All the latest regulatory updates compiled for you by S-cubed.
Articles filtered by tag
Latest news from EMA regarding nitrosamines
Our latest regulatory update focuses on the responsibilities of the Marketing Authorisation Holder.
Our latest Industry Update for Q2 covers the latest regulatory information around COVID-19 and much more.
Latest updates from EMA in response to the COVID-19 pandemic.
The deadline for Nitrosamine Risk Evaluation is looming. Are you ready?
Our first Industry Update of 2020 focuses on Clinical Trial Regulation, Brexit and the latest from FDA & EMA.
With just one month to go, have you completed your risk evaluations? Make sure you are ready!
The EU Pilot for 2 Member States to gain simultaneous national scientific advice is launched on 1st February. Find out more here.
Two Months to Go – Human medicinal product licences to be reviewed for the presence of Nitrosamine Impurities
Nitrosamines, TOPRA, & Drug Development News are the focus for our Q4 Industry Insights
Global Harmonisation of Clinical Trials is the latest focus for our quarterly roundup of the regulatory landscape with news from EMA, FDA and ICH